Cargando…
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells
[Image: see text] The mitochondrial SIRT3 modulates several biological pathways such as cancer, metabolism, and hypoxia-related diseases. Recently, we discovered new 1,4-dihydropyridines, compounds 2 and 3, the latter being a SIRT3-specific activator. In the present work, a novel 2- and 3-related sm...
Autores principales: | Zwergel, Clemens, Aventaggiato, Michele, Garbo, Sabrina, Di Bello, Elisabetta, Fassari, Bruno, Noce, Beatrice, Castiello, Carola, Lambona, Chiara, Barreca, Federica, Rotili, Dante, Fioravanti, Rossella, Schmalz, Thomas, Weyand, Michael, Niedermeier, Amelie, Tripodi, Marco, Colotti, Gianni, Steegborn, Clemens, Battistelli, Cecilia, Tafani, Marco, Valente, Sergio, Mai, Antonello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388363/ https://www.ncbi.nlm.nih.gov/pubmed/37439550 http://dx.doi.org/10.1021/acs.jmedchem.3c00337 |
Ejemplares similares
-
Selenium-Containing Agents Acting on Cancer—A New Hope?
por: Garbo, Sabrina, et al.
Publicado: (2022) -
A novel RNA-based approach to counteract EMT
por: Garbo, Sabrina, et al.
Publicado: (2021) -
lncRNA HOTAIR functions and therapeutic perspectives
por: Garbo, Sabrina, et al.
Publicado: (2022) -
Sirtuins and Hypoxia in EMT Control
por: Aventaggiato, Michele, et al.
Publicado: (2022) -
Next RNA Therapeutics: The Mine of Non-Coding
por: Garbo, Sabrina, et al.
Publicado: (2022)